ICUI · XBRL financial data

Icu Medical financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ICUI's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	1,271	1,316	2,280	2,259	2,382	2,231
Cost of goods and services sold	810	825	1,582	1,519	1,557	1,409
Gross profit	461	491	698	740	825	822
Research and development	43	47	93	85	89	87
Selling, general and administrative	284	303	608	607	639	625
Total operating expenses	363	368	741	717	782	779
Other operating income (expense)	(3)	(2)	(5)	(6)	(13)	(0)
Operating income (loss)	98	123	(43)	23	43	43
Interest expense	2	1	71	103	107	93
Income tax expense (benefit)	11	20	(40)	(49)	52	2
Net income (loss)	87	103	(74)	(30)	(118)	1
Earnings per share, basic USD per share	4.16	4.86	(3.11)	(1.23)	(4.83)	0.03
Earnings per share, diluted USD per share	4.02	4.74	(3.11)	(1.23)	(4.83)	0.03
Weighted average shares, basic millions of shares	21	21	24	24	24	25
Weighted average shares, diluted millions of shares	22	22	24	24	24	25

Fiscal years (ICUI's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	396	553	209	254	309	308
Marketable securities	15	14	4	1	0	—
Marketable securities, non-current	13	5	1	0	—	—
Accounts receivable	124	106	222	162	183	181
Inventory	315	290	696	709	585	616
Prepaid and other current assets	41	47	89	74	70	86
Total current assets	921	1,030	1,235	1,221	1,442	1,191
Property and equipment, net	467	468	636	613	443	452
Right-of-use asset	47	40	75	70	53	54
Goodwill	33	43	1,449	1,472	1,433	1,500
Total assets	1,764	1,881	4,516	4,378	4,204	4,051
Accounts payable	72	81	216	150	148	154
Accrued liabilities	97	118	243	268	307	315
Current portion of long-term debt	—	0	30	51	51	19
Total current liabilities	195	201	495	482	556	499
Long-term debt	—	0	1,624	1,578	1,532	1,266
Lease liability, non-current	41	34	61	53	41	44
Retained earnings	809	912	838	808	690	691
Total stockholders' equity	1,502	1,616	2,090	2,123	1,965	2,124
Total liabilities and equity	1,764	1,881	4,516	4,378	4,204	4,051
Common shares outstanding (cover page) millions of shares	21	24	24	24	25	25

Fiscal years (ICUI's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	87	103	(74)	(30)	(118)	1
Stock-based compensation	24	27	36	41	47	56
Depreciation and amortization	86	90	235	229	220	201
Net cash from operating activities	223	268	(62)	166	204	180
Purchases of property and equipment	92	69	90	84	79	88
Net cash from investing activities	(98)	(91)	(1,909)	(88)	(89)	122
Share repurchases	13	8	11	9	12	9
Repayments of long-term debt	150	0	22	30	51	303
Net cash from financing activities	(0)	(17)	1,637	(36)	(56)	(312)
Net change in cash	127	157	(344)	45	54	(1)

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Icu Medical	298	552	80*	25.0M	—	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	228	94	(19)*	57.3M	11.8 quarters	Q2 FY26 10-QJun 30, 2026
Dentsply Sirona	239	898	99*	199.4M	—	Q2 FY26 10-QJun 30, 2026
Inspire Medical Systems	191	207	46*	29.0M	—	Q3 FY26 10-QSep 30, 2026
Masimo	125	404	45	52.4M	—	Q1 FY26 10-QApr 4, 2026
LivaNova	517	391	67*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
Integer Holdings	14	450	37*	34.0M	—	Q3 FY26 10-QOct 2, 2026
TransMedics Group	491	190	17*	34.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.